| Objective To analyze the screening situation of urban cancer early diagnosis and treatment projects in Shaanxi Province from 2021 to 2022. Methods The risk assessment and clinical screening data of five types of high incidence malignant tumors (breast cancer, lung cancer, upper gastrointestinal cancer, liver cancer, colorectal cancer) in the urban cancer early diagnosis and treatment project in Shaanxi Province were summarized and analyzed. Analyze the high-risk rate, screening compliance rate, and positive detection rate of the above 5 types of malignant tumors. Results A total of 17921 people successfully completed the survey, and the proportion of males participating in screening (44.12%) was lower than that of females (55.88%). A total of 9270 high-risk people were evaluated, with a preliminary screening high risk rate of 51.7%. The high risk rates of five types of cancer were 34.2% for breast cancer, 24.2% for lung cancer, 20.7% for upper gastrointestinal cancer, 7.5% for liver cancer, and 29.8% for colorectal cancer. Among the 18145 individuals assessed as high-risk in the initial screening, a total of 6357 individuals underwent clinical screening, with a screening compliance rate of 35.0%. The number of people who received clinical screening and the compliance rate of screening for five types of cancer were 1451 (42.3%) for breast cancer, 2064 (47.7%) for lung cancer, 1125 (30.4%) for upper gastrointestinal cancer, 468 (35.0%) for liver cancer, and 1249 (23.4%) for colorectal cancer. The number of people who were positive and the detection rate were 142 (9.8%) for breast cancer, 373 (18.1%) for lung cancer, 13 (1.2%) for upper gastrointestinal cancer, 8 (1.7%) for liver cancer, and 68 (5.4%) for colorectal cancer. Conclusions Shaanxi Province launched the early diagnosis and treatment project for urban cancer screening relatively late. The characteristics of the population participating in screening, high-risk population, and clinical screening population vary in different years. It is necessary to further analyze the cancer screening data of each region in a timely and complete manner, adjust the promotion and screening time in a timely manner, improve the screening methods, increase population participation, increase screening accuracy, and further strengthen the understanding and cooperation of the population towards early diagnosis and treatment of cancer. |
